Badriah M. Almutairi

Public motives and willingness to participate in first-in-human clinical trials in Saudi Arabia: A new era in the making.

H. Balkhy, M. Salam, Adel F. Almutairi, 2019, Journal of infection and public health.

Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.

Z. Memish, F. Hayden, R. Fowler, 2020, The New England journal of medicine.

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

Y. Arabi, A. Bouchama, Faisal Alharbi, 2021, Infectious Diseases and Therapy.

Heterogeneity of treatment effect of interferon-β1b and lopinavir–ritonavir in patients with Middle East respiratory syndrome by cytokine levels

Z. Memish, F. Hayden, R. Fowler, 2022, Scientific Reports.

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial

Mohammed J. F. Alenazi, Lindsey B. Rosen, Y. Arabi, 2023, Influenza and other respiratory viruses.